Earnings · China A-shares
Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A (603168) earnings
Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A published its Q3 report on 2026-10-30: net profit -336.40% year on year, -942.38% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -1.95% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -336.40%
- Excl. one-offs YoY
- -942.38%
- Net profit QoQ
- -286.00%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.19% | — |
| 3 days | -1.95% | — |
| 7 days | -0.78% | — |
| 14 days | -10.51% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 3 of 7 reports (average +1.65%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥65.32M | -336.40% | — | -15.44% | -0.17 | -4.95% | -1.95% | — | — |
| 2026 interim report | 2026-08-31 | ¥19.50M | -10.81% | — | -16.77% | 0.05 | 1.43% | -1.66% | -3.48% | +5.85% |
| 2026 Q1 report | 2026-04-30 | -¥26.10M | -394.89% | +116.21% | -3.15% | -0.07 | -1.95% | -0.89% | -21.66% | -23.71% |
| 2025 annual report | 2026-04-15 | -¥238.72M | -93.39% | — | -4.38% | -0.64 | -16.24% | -3.41% | -14.24% | -18.79% |
| 2025 Q3 report | 2025-10-31 | ¥27.63M | +189.85% | +108.60% | -2.44% | 0.07 | 1.72% | +0.50% | -4.99% | -0.31% |
| 2025 interim report | 2025-08-30 | ¥21.86M | +188.45% | +186.45% | -0.32% | 0.06 | 1.37% | +8.64% | +2.75% | +1.91% |
| 2025 Q1 report | 2025-04-30 | ¥8.85M | +106.03% | — | -26.19% | 0.02 | 0.56% | +10.34% | +16.05% | +12.87% |
| 2024 annual report | 2025-04-30 | -¥123.44M | -585.85% | — | -24.96% | -0.33 | -7.46% | +10.34% | +16.05% | +12.87% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.